Charlie Barker Named Director Of Scientific Services At SNBL USA

EVERETT, Wash.--(BUSINESS WIRE)--SNBL USA, the experts in preclinical research, today announced Charlie Barker has joined the executive team to serve as the Director of Scientific Services. In this position Charlie will assume leadership for all scientific technical service activities and associated personnel. He will implement and execute strategic plans, policies, and procedures to ensure SNBL USA's toxicology services meet or exceed clients' needs, timelines, quality, and regulatory requirements.

"Charlie's experience and wide range of technical expertise in the industry positions him as an ideal catalyst to help guide SNBL USA to the next level of excellence in our preclinical service offerings."

"We are excited to have Charlie on board to provide strategic direction to the scientific services team," said Steve Glaza, SNBL USA chief operating officer. "Charlie's experience and wide range of technical expertise in the industry positions him as an ideal catalyst to help guide SNBL USA to the next level of excellence in our preclinical service offerings."

Charlie Barker has over 22 years industry experience in the toxicology field, including government research laboratories, and is well-versed in many areas of the drug development process. Prior to joining SNBL USA, he has held various positions including senior director of technical operations at WuXi AppTec, operations manager at Charles River, and animal care specialist as a member of the Army Veterinary Corps with assignments at Walter Reed Army Institute of Research, the Naval Medical Research Institute and Tripler Army Medical Center. Mr. Barker holds a Bachelor of Science degree in Biomedical Science from Crown University and is an AALAS-certified Laboratory Animal Technician. Charlie has a strong background in developing successful training programs that produce highly qualified, motivated technical staffs and mentoring staff members in career development.

For additional information regarding SNBL USA services and capabilities, contact us at +1.425.322.1950 or [email protected]

About SNBL USA, Ltd.

Headquartered in Everett, Wash., SNBL USA, Ltd. offers a unique range of safety assessment services to fulfill its commitment to help free patients from suffering. Managed and operated by a team world renowned for its wide-ranging NHP experience and expertise, SNBL USA offers programs ranging from regulatory toxicology to customized study designs in multiple drug classes (biologics, small molecules, oligonucleotides, vaccines, gene therapy).

SNBL USA, Ltd.
Michelle Taylor, MA, 425-322-1950
Marketing Manager
[email protected]

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

While the biotech IPO market booms, it can look like going public is easy. But the right strategy, syndicate and aftermarket are still important.

Gene therapy pioneer Jim Wilson and the University of Pennsylvania are teaming up with Regeneron to help deliver its COVID antibody intransally.

Forty percent of PK deficiency patients on mitapivat had hemoglobalin responses, compared to 0% in the placebo group.